207 related articles for article (PubMed ID: 33529007)
1. Highly Tumor-Specific and Long-Acting Iodine-131 Microbeads for Enhanced Treatment of Hepatocellular Carcinoma with Low-Dose Radio-Chemoembolization.
Qian Y; Liu Q; Li P; Han Y; Zhang J; Xu J; Sun J; Wu A; Song S; Lu W
ACS Nano; 2021 Feb; 15(2):2933-2946. PubMed ID: 33529007
[TBL] [Abstract][Full Text] [Related]
2. Development and physicochemical characterization of a biodegradable microspheres formulation loaded with samarium-153 and doxorubicin for chemo-radioembolization of liver tumours.
Alregib AH; Tan HY; Wong YH; Kasbollah A; Wong EH; Abdullah BJJ; Perkins AC; Yeong CH
J Labelled Comp Radiopharm; 2023 Aug; 66(10):308-320. PubMed ID: 37287213
[TBL] [Abstract][Full Text] [Related]
3. Periodic mesoporous organosilica-coated magnetite nanoparticles combined with lipiodol for transcatheter arterial chemoembolization to inhibit the progression of liver cancer.
Liu L; Xu X; Liang X; Zhang X; Wen J; Chen K; Su X; Ma Y; Teng Z; Lu G; Xu J
J Colloid Interface Sci; 2021 Jun; 591():211-220. PubMed ID: 33609893
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular Carcinoma: Intra-arterial Delivery of Doxorubicin-loaded Hollow Gold Nanospheres for Photothermal Ablation-Chemoembolization Therapy in Rats.
Li J; Zhou M; Liu F; Xiong C; Wang W; Cao Q; Wen X; Robertson JD; Ji X; Wang YA; Gupta S; Li C
Radiology; 2016 Nov; 281(2):427-435. PubMed ID: 27347765
[TBL] [Abstract][Full Text] [Related]
5. In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization?
El Fouly A; Ertle J; El Dorry A; Shaker MK; Dechêne A; Abdella H; Mueller S; Barakat E; Lauenstein T; Bockisch A; Gerken G; Schlaak JF
Liver Int; 2015 Feb; 35(2):627-35. PubMed ID: 25040497
[TBL] [Abstract][Full Text] [Related]
6. DEB TACE for Intermediate and advanced HCC - Initial Experience in a Brazilian Cancer Center.
Luz JH; Luz PM; Martin HS; Gouveia HR; Levigard RB; Nogueira FD; Rodrigues BC; de Miranda TN; Mamede MH
Cancer Imaging; 2017 Feb; 17(1):5. PubMed ID: 28166821
[TBL] [Abstract][Full Text] [Related]
7. Radioembolization of hepatocarcinoma with
Chiesa C; Mira M; Bhoori S; Bormolini G; Maccauro M; Spreafico C; Cascella T; Cavallo A; De Nile MC; Mazzaglia S; Capozza A; Tagliabue G; Brusa A; Marchianò A; Seregni E; Mazzaferro V
Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3018-3032. PubMed ID: 32451604
[TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study.
Kwon JH; Kim GM; Han K; Won JY; Kim MD; Lee DY; Lee J; Choi W; Kim YS; Kim DY; Han KH
Cardiovasc Intervent Radiol; 2018 Mar; 41(3):459-465. PubMed ID: 29067511
[TBL] [Abstract][Full Text] [Related]
9. Comparison of drug release and pharmacokinetics after transarterial chemoembolization using diverse lipiodol emulsions and drug-eluting beads.
Choi JW; Cho HJ; Park JH; Baek SY; Chung JW; Kim DD; Kim HC
PLoS One; 2014; 9(12):e115898. PubMed ID: 25551760
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional microbeads for drug delivery in TACE.
Bannerman D; Wan W
Expert Opin Drug Deliv; 2016 Sep; 13(9):1289-300. PubMed ID: 27223469
[TBL] [Abstract][Full Text] [Related]
11. Transarterial Chemoembolization in a Woodchuck Model of Hepatocellular Carcinoma.
Pritchard WF; Woods DL; Esparza-Trujillo JA; Starost MF; Mauda-Havakuk M; Mikhail AS; Bakhutashvili I; Leonard S; Jones EC; Krishnasamy V; Karanian JW; Wood BJ
J Vasc Interv Radiol; 2020 May; 31(5):812-819.e1. PubMed ID: 32107125
[TBL] [Abstract][Full Text] [Related]
12. Radioiodine-131-Labeled Theranostic Nanoparticles for Transarterial Radioembolization and Chemoembolization Combination Therapy of VX2 Liver Tumor.
Jia G; Wang T; Li R; Li X; Sun G; Chen W; Peng Y; Cheng C; Yang J; Zuo C
Adv Healthc Mater; 2023 Dec; 12(32):e2301559. PubMed ID: 37807421
[TBL] [Abstract][Full Text] [Related]
13. Transarterial chemoembolization versus transarterial radioembolization in hepatocellular carcinoma: optimization of selecting treatment modality.
Kim DY; Han KH
Hepatol Int; 2016 Nov; 10(6):883-892. PubMed ID: 27126821
[TBL] [Abstract][Full Text] [Related]
14. Drug-Eluting Microsphere Versus Cisplatin-Based Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma: Propensity Score-Matched Analysis.
Chu HH; Gwon DI; Kim JH; Ko GY; Shin JH; Yoon HK
AJR Am J Roentgenol; 2020 Sep; 215(3):745-752. PubMed ID: 32569514
[No Abstract] [Full Text] [Related]
15. Development and Validation of Sorafenib-eluting Microspheres to Enhance Therapeutic Efficacy of Transcatheter Arterial Chemoembolization in a Rat Model of Hepatocellular Carcinoma.
Park W; Cho S; Ji J; Lewandowski RJ; Larson AC; Kim DH
Radiol Imaging Cancer; 2021 Jan; 3(1):e200006. PubMed ID: 33575658
[TBL] [Abstract][Full Text] [Related]
16. Biodegradable
Pang F; Li Y; Zhang W; Xia C; He Q; Li Z; Xiao L; Song S; Dong P; Zhou H; Shao T; Cai H; Li L
Adv Healthc Mater; 2020 Jul; 9(13):e2000028. PubMed ID: 32431090
[TBL] [Abstract][Full Text] [Related]
17. Relationship of Tumor Radiation-absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with
Hermann AL; Dieudonné A; Ronot M; Sanchez M; Pereira H; Chatellier G; Garin E; Castera L; Lebtahi R; Vilgrain V;
Radiology; 2020 Sep; 296(3):673-684. PubMed ID: 32602828
[TBL] [Abstract][Full Text] [Related]
18. Polymersome-stabilized doxorubicin-lipiodol emulsions for high-efficacy chemoembolization therapy.
Liu J; Zhang L; Zhao D; Yue S; Sun H; Ni C; Zhong Z
J Control Release; 2022 Oct; 350():122-131. PubMed ID: 35973474
[TBL] [Abstract][Full Text] [Related]
19.
Wu X; Ge L; Shen G; He Y; Xu Z; Li D; Mu C; Zhao L; Zhang W
ACS Appl Mater Interfaces; 2022 May; 14(19):21848-21859. PubMed ID: 35507826
[TBL] [Abstract][Full Text] [Related]
20. Local application of doxorubicin- loaded Iron oxid nanoparticles and the vascular disrupting agent via the hepatic artery: chemoembolization-photothermal ablation treatment of hepatocellular carcinoma in rats.
Yuan H; Li X; Tang J; Zhou M; Liu F
Cancer Imaging; 2019 Nov; 19(1):71. PubMed ID: 31685015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
